Lekhim, a leading Ukrainian pharmaceutical company specializing in generic drugs, recently held discussions with the Agency for the Development of the Pharmaceutical Network in Uzbekistan on October 13th. The talks primarily revolved around Lekhim's plan to establish a pharmaceutical production facility in the Kybray district of the Tashkent region in Uzbekistan.
Lekhim is a prominent player in Ukraine's pharmaceutical industry, particularly in the sales of enzyme preparations, suppositories, and granular preparations.
A significant announcement made during the meeting was Lekhim's commitment to constructing a pharmaceutical factory in Uzbekistan with an annual production capacity of 50mn ampoule-shaped drugs. This investment underlines Lekhim's commitment to both growing its presence in Uzbekistan and contributing to the development of the country's pharmaceutical industry.
The meeting primarily focused on the practical aspects of the project and the necessary collaborative efforts. The cooperation between Lekhim and the Agency for the Development of the Pharmaceutical Network is expected to play a vital role in advancing this initiative.
The partnership between Lekhim and Uzbekistan has the potential to positively impact the country's healthcare sector. It brings expertise and resources to Uzbekistan and offers prospects for economic growth and employment opportunities. As Lekhim proceeds with plans for the pharmaceutical production facility, the company's aim is to improve healthcare access and support the development of Uzbekistan's pharmaceutical industry.
Follow Daryo's official Instagram and Twitter pages to keep current on world news.
Comments (0)